申请人:Medicinal Bioconvergence Research Center
公开号:US20150038531A1
公开(公告)日:2015-02-05
An aminopyridine derivative of Formula 1 and a method of preventing or treating cancer using the same. Formula 1:
In Formula 1: X1 and X2 are each independently selected from the group consisting of carbon and nitrogen; R1 to R5 are each independently selected from the group consisting of a hydrogen, a straight, a branched, or cyclo alkyl of C1-C4, a halogen, and a hydroxyl; and R6 is a hydrogen or an alkyl of C1-C6.